V-161, a novel compound targeting the Na +-V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. This breakthrough offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback